Skip to main content
. Author manuscript; available in PMC: 2013 Aug 20.
Published in final edited form as: Am J Hypertens. 2008 Jul 24;21(10):1137–1143. doi: 10.1038/ajh.2008.240

Table 1.

Comparison of Baseline Characteristics by Randomization Group

Characteristic Value, n (%)

Intervention (n = 95) Control (n = 95) p-value

Mean Age +/− SD 53.45 (11.35) 54.04 (12.81) .29
Female (%) 84 (50) 84 (50) .59
Marital Status (%)
    Single 49 (58) 35 (42)
    Married 13 (39) 20 (61) .12
    Separated 26 (45) 32 (55)
    Widower 7 (47) 8 (53)
Education (%)
    Elementary 21 (48) 23 (52)
    High school/GED 41 (48) 44 (52) .49
    Some college 33 (54) 28 (46)
Employment Status (%)
    Employed full time 15 (52) 14 (48)
    Employed part time 8 (62) 5 (38)
    Retired 12 (60) 8 (40) .29
    Not working 60 (45) 68 (55)
Type of insurance (%)
    HMO 11 (85) 2 (15)
    Medicare 11 (50) 11 (50) .06
    Medicaid 65 (46) 75 (54)
    Self 8 (53) 7 (47)
Annual income (%)
    Unknown 14 (48) 15 (52)
    ≤$20,000 58 (48) 64 (52) .33
    >$20,000 23 (59) 16 (41)
    CHF (%) 6 (43) 8 (57) .42
    Stroke (%) 11 (44) 14 (56) .37
    Diabetes (%) 31 (51) 30 (49) .44
    Kidney disease (%) 4 (57) 3 (43) .48
Charlson Comorbidity Score (%)
    0 12 (35) 22 (65) .43
    1-2 34 (55) 28 (45)
    ≥3 36 (51) 35 (49)
Mean DBP (+/− SD) 145.79 (19.76) 143.11 (18.36) .33
Mean SBP (+/− SD) 86.22 (11.67) 87.09 (12.49) .59
Antihypertensive Medications (%)
    ACE-Inhibitor 43 (45) 32 (34) 0.47
    Beta Blocker 29 (31) 28 (30) 0.76
    Calcium Channel Blocker 27 (28) 28 (30) 0.76
    Diuretic 32 (34) 39 (41) 0.64
    Combination 20 (21) 21 (22) 0.76

p-value indicates differences in values between intervention and control groups

HMO: Healthcare Maintenance Organization SBP: Systolic Blood Pressure; DBP: Diastolic Blood Pressure